EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Rituximab for double-positive anti-GBM antibody and ANCA-associated glomerulonephritis: The first reported case in Asia and literature review

Chang-Ying Chen, Ying-Ren Chen, Wei-Ren Lin, Wei-Hung Lin

Clinical Nephrology · 2025

DOI: 10.5414/cn111588 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Nephrology, 2025. Verfasst von Chang-Ying Chen und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Anti-Glomerular Basement Membrane Disease, Antibodies, Antineutrophil Cytoplasmic, Glomerulonephritis, Rituximab. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Glomerular Basement Membrane DiseaseAntibodies, Antineutrophil CytoplasmicGlomerulonephritisRituximabFemaleHumansMiddle AgedCreatinineDisease ProgressionImmunologic FactorsInduction ChemotherapyMaintenance ChemotherapyTreatment OutcomeCyclophosphamide

Substanzen

anti-glomerular basement membrane autoantibodyAntibodies, Antineutrophil CytoplasmicCreatinineImmunologic FactorsRituximabCyclophosphamide

Zitieren

APA

Chen, C. Y., Chen, Y. R., Lin, W. R., & Lin, W. H. (2025). Rituximab for double-positive anti-GBM antibody and ANCA-associated glomerulonephritis: The first reported case in Asia and literature review. Clinical Nephrology. https://doi.org/10.5414/cn111588

Vancouver

Chen CY, Chen YR, Lin WR, Lin WH. Rituximab for double-positive anti-GBM antibody and ANCA-associated glomerulonephritis: The first reported case in Asia and literature review. Clinical Nephrology. 2025. doi:10.5414/cn111588

BibTeX
@article{Chen2025,
  author = {Chen, Chang-Ying and Chen, Ying-Ren and Lin, Wei-Ren and Lin, Wei-Hung},
  title = {Rituximab for double-positive anti-GBM antibody and ANCA-associated glomerulonephritis: The first reported case in Asia and literature review},
  journal = {Clinical Nephrology},
  year = {2025},
  doi = {10.5414/cn111588}
}
Kostenlos starten →